LMAT
LEMAITRE VASCULAR INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$85.27
+2.90%Year over year
Reported trailing growth
- Revenue
- +11.8%
- EBITDA
- +24.3%
- EBIT
- +41.2%
- EPS
- +38.1%
- Free cash flow
- +41.1%
- Operating cash flow
- +41.2%
Forward estimates
Based on analyst estimates
- Revenue
- +13.2%
- EBITDA
- +23.1%
- EPS
- +8.5%
Three-year CAGR
- Revenue
- +15.6%
- EBITDA
- +35.0%
- EBIT
- +36.3%
- Net income
- +40.9%
- EPS
- +39.5%
- Free cash flow
- +49.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026